Literature DB >> 29145709

Review: Defining a Unified Vascular Phenotype in Systemic Sclerosis.

Yannick Allanore1, Oliver Distler2, Marco Matucci-Cerinic3, Christopher P Denton4.   

Abstract

Microcirculation impairment and related vasculopathy are hallmarks of systemic sclerosis (SSc). Digital ulceration is second only to Raynaud's phenomenon as a vascular complication occurring in patients with SSc. Digital ulcers are painful and generate disability. Furthermore, patients may develop recurrent digital ulcers, and it is reasonable to question whether the outcomes of such patients might be different from those of patients who are not affected. Recently, several registries have provided relevant information about digital ulcers. Male sex and severe skin disease appear to be the main associated factors observed in several registries. However, limitations of those studies are the differences in the definitions of digital ulcers and organ involvement. Few longitudinal studies are available, and the more robust data from the European League Against Rheumatism Scleroderma Trial and Research cohort suggested worse outcomes in patients with a history of digital ulcers but could not demonstrate that a history of digital ulcers can predict additional vascular complications such as pulmonary arterial hypertension, heart failure, or renal crisis. Nevertheless, the autopsy studies published many years ago and the more recent longitudinal biomarker studies support the concept of generalized vasculopathy and a potential association between various cardiovascular complications. It is expected that with the availability of several structured registries, identification of a vascular profile or vascular phenotype will be addressed using more robust data in the near future.
© 2017, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29145709     DOI: 10.1002/art.40377

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  9 in total

1.  Increased serum uric acid levels are associated with digital ulcers in patients with systemic sclerosis.

Authors:  Eunsung Kim; Han-Na Lee; Yun-Kyung Kim; Geun-Tae Kim; Min Wook So; Eunyoung Ahn; Dong Hyun Sohn; Seung-Geun Lee
Journal:  Rheumatol Int       Date:  2019-01-17       Impact factor: 2.631

2.  Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival.

Authors:  Kathleen Morrisroe; Dylan Hansen; Wendy Stevens; Joanne Sahhar; Gene-Siew Ngian; Catherine Hill; Janet Roddy; Jennifer Walker; Susanna Proudman; Mandana Nikpour
Journal:  Arthritis Res Ther       Date:  2022-05-10       Impact factor: 5.606

Review 3.  New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine.

Authors:  Alain Lescoat; John Varga; Marco Matucci-Cerinic; Dinesh Khanna
Journal:  Expert Opin Investig Drugs       Date:  2021-05-13       Impact factor: 6.498

4.  Soluble CD163 as a Potential Biomarker in Systemic Sclerosis.

Authors:  Camelia Frantz; Sonia Pezet; Jerome Avouac; Yannick Allanore
Journal:  Dis Markers       Date:  2018-04-01       Impact factor: 3.434

5.  A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis.

Authors:  Annemarie Schorpion; Max Shenin; Robin Neubauer; Chris T Derk
Journal:  BMC Rheumatol       Date:  2018-05-15

6.  Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence.

Authors:  Mirko Manetti; Eloisa Romano; Irene Rosa; Bianca Saveria Fioretto; Serena Guiducci; Silvia Bellando-Randone; Erika Pigatto; Franco Cozzi; Lidia Ibba-Manneschi; Marco Matucci-Cerinic
Journal:  Int J Mol Sci       Date:  2019-12-07       Impact factor: 5.923

7.  Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers.

Authors:  Ivan Castellví; Carmen Pilar Simeón; Monica Sarmiento; Jordi Casademont; Hèctor Corominas; Vicenç Fonollosa
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

8.  Systemic sclerosis sine scleroderma in children.

Authors:  Francesco Zulian; Gloria Lanzoni; Biagio Castaldi; Alessandra Meneghel; Francesca Tirelli; Elisabetta Zanatta; Giorgia Martini
Journal:  Rheumatology (Oxford)       Date:  2022-05-30       Impact factor: 7.046

Review 9.  Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?

Authors:  Cosimo Bruni; Tracy Frech; Mirko Manetti; Francesca Wanda Rossi; Daniel E Furst; Amato De Paulis; Felice Rivellese; Serena Guiducci; Marco Matucci-Cerinic; Silvia Bellando-Randone
Journal:  Front Immunol       Date:  2018-09-07       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.